Risk for congenital malformation with H1N1 influenza vaccine: A cohort study with sibling analysis

Annals of Internal Medicine

Volumn 165, Issue 12, 2016, Pages 848-855

  Ludvigsson, Jonas F ^a   Ström, Peter ^a   Lundholm, Cecilia ^a   Cnattingius, Sven ^a   Ekbom, Anders ^a   Örtqvist, Åke ^b   Feltelius, Nils ^c   Granath, Fredrik ^a   Stephansson, Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b STOCKHOLM COUNTY COUNCIL   (Sweden)

^c MEDICAL PRODUCTS AGENCY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADULT; ARTICLE; COHORT ANALYSIS; CONGENITAL HEART DISEASE; CONGENITAL MALFORMATION; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; INFLUENZA A (H1N1); INFLUENZA VACCINATION; LIMB DEFECT; LIVE BIRTH; MAJOR CLINICAL STUDY; MALE; MOUTH MALFORMATION; NEURAL TUBE DEFECT; NEWBORN; PRENATAL EXPOSURE; PRIORITY JOURNAL; PROGENY; PROSPECTIVE STUDY; RISK ASSESSMENT; SIBLING; SWEDEN; YOUNG ADULT; CONGENITAL ABNORMALITIES; ENVIRONMENT; EPIDEMIOLOGY; GENETICS; INFLUENZA A VIRUS (H1N1); INFLUENZA, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RISK FACTOR;

ADULT; CONFOUNDING FACTORS (EPIDEMIOLOGY); CONGENITAL ABNORMALITIES; ENVIRONMENT; FEMALE; HUMANS; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROSPECTIVE STUDIES; RISK FACTORS; SIBLINGS; SWEDEN; YOUNG ADULT;

EID: 85007257309     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M16-0139     Document Type: Article

References (25)

1. World Health Organization. Implementation of the International Health Regulations (2005). Geneva: World Health Organization; 2011.
2. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, et al; Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med. 2009;360: 2605-15. [PMID: 19423869] doi: 10.1056/NEJMoa0903810
3. Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, et al. Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science. 2009;325: 197-201. [PMID: 19465683] doi: 10.1126/science.1176225
4. New influenza A (H1N1) virus: WHO guidance on public health measures, 11 June 2009. Wkly Epidemiol Rec. 2009;84: 261-4. [PMID: 19557942]
5. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, et al; 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med. 2009;361: 1935-44. [PMID: 19815859] doi: 10.1056/NEJMoa0906695
6. McMillan M, Porritt K, Kralik D, Costi L, Marshall H. Influenza vaccination during pregnancy: A systematic review of fetal death, spontaneous abortion, and congenital malformation safety outcomes. Vaccine. 2015;33: 2108-17. [PMID: 25758932] doi: 10.1016/j.vaccine.2015.02.068
7. Chambers CD, Johnson D, Xu R, Luo Y, Louik C, Mitchell AA, et al; OTIS Collaborative Research Group. Risks and safety of pandemic H1N1 influenza vaccine in pregnancy: Birth defects, spontaneous abortion, preterm delivery, and small for gestational age infants. Vaccine. 2013;31: 5026-32.[PMID: 24016809]doi: 10.1016/j.vaccine.2013.08.097
8. Källén B, Olausson PO. Vaccination against H1N1 influenza with Pandemrix(?) during pregnancy and delivery outcome: A Swedish register study. BJOG. 2012;119: 1583-90. [PMID: 22901103] doi: 10.1111/j.1471-0528.2012.03470.x
9. Mackenzie IS, MacDonald TM, Shakir S, Dryburgh M, Mantay BJ, McDonnell P, et al. Influenza H1N1 (swine flu) vaccination: A safety surveillance feasibility study using self-reporting of serious adverse events and pregnancy outcomes. Br J Clin Pharmacol. 2012;73: 801-11. [PMID: 22082196] doi: 10.1111/j.1365-2125.2011.04142.x
10. Oppermann M, Fritzsche J, Weber-Schoendorfer C, Keller-Stanislawski B, Allignol A, Meister R, et al. A(H1N1)v2009: A controlled observational prospective cohort study on vaccine safety in pregnancy. Vaccine. 2012;30: 4445-52. [PMID: 22564554] doi: 10.1016/j.vaccine.2012.04.081
11. Pasternak B, Svanström H, Mølgaard-Nielsen D, Krause TG, Emborg HD, Melbye M, et al. Risk of adverse fetal outcomes following administration of a pandemic influenza A(H1N1) vaccine during pregnancy. JAMA. 2012;308: 165-74. [PMID: 22782418] doi: 10.1001/jama.2012.6131
12. Sheffield JS, Greer LG, Rogers VL, Roberts SW, Lytle H, McIntire DD, et al. Effect of influenza vaccination in the first trimester of pregnancy. Obstet Gynecol. 2012;120: 532-7. [PMID: 22914461] doi: 10.1097/AOG.0b013e318263a278
13. Ludvigsson JF, Otterblad-Olausson P, Pettersson BU, Ekbom A. The Swedish personal identity number: Possibilities and pitfalls in healthcare and medical research. Eur J Epidemiol. 2009;24: 659-67. [PMID: 19504049] doi: 10.1007/s10654-009-9350-y
14. Benefits and risks of vaccinations with Pandemrix during pregnancy. Recommendations by the Swedish Medical Products Agency [in Swedish]. Uppsala, Sweden: Swedish Medical Products Agency; 2009.
15. Persson I, Granath F, Askling J, Ludvigsson JF, Olsson T, Feltelius N. Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: A population-And registrybased cohort study with over 2 years of follow-up. J Intern Med. 2014;275: 172-90. [PMID: 24134219] doi: 10.1111/joim.12150
16. Cnattingius S, Ericson A, Gunnarskog J, Källén B. A quality study of a medical birth registry. Scand J Soc Med. 1990;18: 143-8. [PMID: 2367825]
17. Cnattingius S, Villamor E, Johansson S, Edstedt Bonamy AK, Persson M, Wikström AK, et al. Maternal obesity and risk of preterm delivery. JAMA. 2013;309: 2362-70. [PMID: 23757084] doi: 10.1001/jama.2013.6295
18. World Health Organization. Global Database on Body Mass Index. BMI Classification. Geneva: World Health Organization. Accessed at http://apps.who.int/bmi/index.jsp?introPage=intro-3.html on 11 August 2016.
19. Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: Population based cohort study in Stockholm, Sweden. BMJ. 2011;343: D5956. [PMID: 21994316] doi: 10.1136/bmj.d5956
20. Høgberg U, Larsson N. Early dating by ultrasound and perinatal outcome. A cohort study. Acta Obstet Gynecol Scand. 1997;76: 907-12. [PMID: 9435727]
21. Ludvigsson JF, Almqvist C, Bonamy AK, Ljung R, Michaëlsson K, Neovius M, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31: 125-36. [PMID: 26769609] doi: 10.1007/s10654-016-0117-y
22. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish National Inpatient Register. BMC Public Health. 2011;11: 450. [PMID: 21658213] doi: 10.1186/1471-2458-11-450
23. Källén BA. Methodological issues in the epidemiological study of the teratogenicity of drugs. Congenit Anom (Kyoto). 2005;45: 44-51. [PMID: 15904431]
24. Sjölander A. Regression standardization with the R package stdReg. Eur J Epidemiol. 2016;31: 563-74. [PMID: 27179798] doi: 10.1007/s10654-016-0157-3
25. Ludvigsson JF, Håberg SE, Knudsen GP, Lafolie P, Zoega H, Sarkkola C, et al. Ethical aspects of registry-based research in the Nordic countries. Clin Epidemiol. 2015;7: 491-508. [PMID: 26648756] doi: 10.2147/CLEP.S90589